All Stories

  1. Berberine hydrochloride-caffeic acid loaded polymeric nanoparticle based hydrogel formulation for topical management of skin inflammation and atopic dermatitis: In vivo studies

    Article • Journal of Drug Delivery Science and Technology, September 2026, Elsevier

    Dr RAJENDRA AWASTHI

  2. Nanoenabled Hyaluronic Acid-Based Topical Delivery of Kaempferol and Ferulic Acid: Chemomodulatory Potential Against DMBA-Croton Oil-Induced Skin Carcinogenesis in Male Swiss Albino Mice

    Article • Pharmaceutics, August 2026, MDPI AG

    Dr RAJENDRA AWASTHI

  3. Formulation, Optimization and In Vitro Cytotoxicity Study of Kaempferol-Loaded PLGA Nanoparticles in Glioblastoma Multiforme Cell Line

    Article • Nano Trends, August 2026, Elsevier

    Dr RAJENDRA AWASTHI

  4. Nanotechnology-Enabled Therapeutics for Alzheimer’s Disease: Advances, Challenges, and Future Directions

    Article • Regenerative Engineering and Translational Medicine, July 2026, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  5. Therapeutic potential of hyaluronic acid: Advanced drug delivery applications with an especial emphasis on psoriasis and atopic dermatitis

    Article • Next Materials, July 2026, Elsevier

    Dr RAJENDRA AWASTHI

  6. Curcumin–piperine liposomal hydrogel formulation for topical management of atopic dermatitis and associated skin inflammation: optimization, in vitro and in vivo studies

    Article • Inflammopharmacology, February 2026, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  7. Nanoencapsulation of Ferulic Acid and Kaempferol in PLGA Nanoparticles: Optimization, In Ovo HET-CAM Assay and In Vitro Characterization

    Article • BioNanoScience, January 2026, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  8. Frontiers and challenges in brain drug delivery: Emerging nanotechnology approaches to overcome the blood-brain barrier for neurodegenerative disease treatment

    Article • Journal of Drug Delivery Science and Technology, January 2026, Elsevier

    Dr RAJENDRA AWASTHI

  9. Drug Delivery and Biomedical Applications of Porous Silicon-Based Nanocarriers

    Article • January 2026, Elsevier

    Dr RAJENDRA AWASTHI

  10. Development and Characterization of <em>Asparagus racemosus</em> and Legume-Based Premix Supplement for Women’s Reproductive Health

    Article • December 2025, MDPI AG

    Dr RAJENDRA AWASTHI

  11. Translational potential of natural bioactive-based formulations in atopic dermatitis: Current insights

    Article • Medicine in Novel Technology and Devices, December 2025, Elsevier

    Dr RAJENDRA AWASTHI

  12. Validation of UV spectrophotometric method for simultaneous estimation of vanillin and kaempferol in a binary mixture and pharmaceutical dosage form

    Article • Accreditation and Quality Assurance, October 2025, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  13. Corrigendum to “Topical transferosomal gel of berberine HCl and diacerein reduced TNF-α and IL-17A levels and reduced epidermal thickness in imiquimod-induced psoriatic BALB/c mice” [J. Drug Deliv. Sci. Technol. (106) (2025) 106731]

    Article • Journal of Drug Delivery Science and Technology, October 2025, Elsevier

    Dr RAJENDRA AWASTHI

  14. Berberine Hydrochloride and Caffeic Acid Loaded Dual Delivery PLGA Nanoparticles: Optimization, In Vitro, and In Ovo Studies

    Article • BioNanoScience, September 2025, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  15. Bovine Serum Albumin-Based Nanoparticles Embedded In Situ Nasal Gel for Brain Delivery of Donepezil: In Vitro and In Vivo Studies

    Article • BioNanoScience, August 2025, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  16. Jute fiber crystalline cellulose grafted polysaccharide: Preparation, grafting and optimization for drug delivery applications

    Article • International Journal of Biological Macromolecules, August 2025, Elsevier

    Dr RAJENDRA AWASTHI

  17. Synthesis and Characterization of Novel HPMC Phthalate Succinate Polymers for Pharmaceutical Applications

    Article • Indian Journal of Pharmaceutical Education and Research, July 2025, EManuscript Services

    Dr RAJENDRA AWASTHI

  18. Retraction of “Intranasally Co-administered Berberine and Curcumin Loaded in Transfersomal Vesicles Improved Inhibition of Amyloid Formation and BACE-1”

    Article • ACS Omega, July 2025, American Chemical Society (ACS)

    Dr RAJENDRA AWASTHI

  19. PLGA nanoparticles as promising drug delivery carrier: the future of skin cancer treatment

    Article • Journal of Umm Al-Qura University for Applied Sciences, June 2025, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  20. Enzymatic Hydrolysis of Perilla Seed Protein: Optimization, Physico-Functional Evaluation, and Structural Characterization

    Article • Food Analytical Methods, May 2025, Springer Science + Business Media

    Dr RAJENDRA AWASTHI, Pramod K Prabhakar

  21. Machine Learning in Healthcare

    Article • May 2025, Taylor & Francis

    Dr RAJENDRA AWASTHI

  22. Vetiver, Vetiveria zizanioides (L.) Nash: Biotechnology, Biorefineries, and the Production of Volatile Phytochemicals

    Article • Plants, May 2025, MDPI AG

    Dr RAJENDRA AWASTHI

  23. Iron Homeostasis and Metabolism During Pregnancy: Exploring Innovative Drug Delivery Approaches for Treating Iron Deficiency Anemia in Pregnant Women

    Article • Archiv der Pharmazie, May 2025, Wiley

    Dr RAJENDRA AWASTHI

  24. Topical transferosomal gel of berberine HCl and diacerein reduced TNF-α and IL-17A levels and reduced epidermal thickness in imiquimod-induced psoriatic BALB/c mice

    Article • Journal of Drug Delivery Science and Technology, April 2025, Elsevier

    Dr RAJENDRA AWASTHI

  25. Curcumin-loaded nanoemulsion for acute lung injury treatment via nebulization: Formulation, optimization and in vivo studies

    Article • ADMET & DMPK, March 2025, International Association of Physical Chemists (IAPC)

    Dr RAJENDRA AWASTHI

  26. Bone Marrow Delivery of Nilotinib Hydrochloride Through Nanoparticles for Therapy of Chronic Myeloid Leukemia

    Article • BioNanoScience, March 2025, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  27. Optimization of ultrasound mediated extraction of perilla protein isolate: study of ultrasonication effect on amino acid profile and functional characteristics

    Article • Journal of Food Measurement & Characterization, February 2025, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  28. Unveiling the role of nanoparticle-based therapeutic strategies for pulmonary drug delivery

    Article • Journal of Drug Delivery Science and Technology, February 2025, Elsevier

    Dr RAJENDRA AWASTHI

  29. Nanoemulsion-Based Nystatin Delivery: Formulation and Characterization Studies

    Article • BioNanoScience, December 2024, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  30. Cocos nucifera Husk Biomass as an Effective Adsorbent for Industrial Wastewater Removal: Harnessing the Power of Nature

    Article • Recent Advances in Food Nutrition & Agriculture, December 2024, Bentham Science Publishers

    Dr RAJENDRA AWASTHI

  31. Advancements in psoriasis management: Integrating nutrient supplement with gut-brain-skin connection

    Article • PharmaNutrition, December 2024, Elsevier

    Dr RAJENDRA AWASTHI

  32. Surface-modified liposomal in-situ nasal gel enhances brain targeting of berberine hydrochloride for Alzheimer’s therapy: optimization and in vivo studies

    Article • Journal of Liposome Research, November 2024, Taylor & Francis

    Dr RAJENDRA AWASTHI

  33. Estimation of Rheological Coefficients of Acacia nilotica Gum: A Versatile Biopolymer for Biomedical and Food Industries

    Article • Current Nutrition & Food Science, October 2024, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, Rishabha Malviya

  34. Synthesis of Novel Acrylamide Graft Copolymer of Acacia nilotica Gum for the Stabilization of Melatonin Nanoparticles for Improved Therapeutic Effect: Optimization Using (3)2 Factorial Design

    Article • Assay and Drug Development Technologies, September 2024, Mary Ann Liebert Inc

    Dr RAJENDRA AWASTHI

  35. Development of Epigallocatechin and Ascorbic Acid Dual Delivery Transferosomes for Managing Alzheimer’s Disease: In Vitro and in Vivo Studies

    Article • ACS Omega, August 2024, American Chemical Society (ACS)

    Dr RAJENDRA AWASTHI

  36. Monoclonal Antibodies and Antibody-drug Conjugates as Emerging Therapeutics for Breast Cancer Treatment

    Article • Current Drug Delivery, August 2024, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, Dr Gaurav Gupta, Vimal Arora, Swati Saini

  37. Optimizing gefitinib nanoliposomes by Box-Behnken design and coating with chitosan: A sequential approach for enhanced drug delivery

    Article • ADMET & DMPK, July 2024, International Association of Physical Chemists (IAPC)

    Dr RAJENDRA AWASTHI

  38. Harnessing nanotechnology for enhanced delivery of erlotinib: a dynamic duo in cancer treatment

    Article • Beni-Suef University Journal of Basic and Applied Sciences, July 2024, Springer Science + Business Media

    Mr. Rajat Goyal, Dr RAJENDRA AWASTHI

  39. Exploring the Potential of Pectin for Gastro Retentive Drug Delivery Systems: From Orchard to Drug Delivery

    Article • Current Drug Therapy, July 2024, Bentham Science Publishers

    Dr RAJENDRA AWASTHI

  40. Essential Oils

    Article • July 2024, Taylor & Francis

    Dr RAJENDRA AWASTHI

  41. Formulation and optimization of electrospun nanofiber films for ultrafast delivery of domperidone: In vitro and in-vivo characterization

    Article • Journal of Drug Delivery Science and Technology, May 2024, Elsevier

    Dr RAJENDRA AWASTHI

  42. Berberine HCl and diacerein loaded dual delivery transferosomes: Formulation and optimization using Box-Behnken design

    Article • ADMET & DMPK, April 2024, International Association of Physical Chemists (IAPC)

    Dr RAJENDRA AWASTHI

  43. Nano-green: Harnessing the potential of plant extracts for sustainable antimicrobial metallic nanoparticles

    Article • Journal of Drug Delivery Science and Technology, April 2024, Elsevier

    Dr RAJENDRA AWASTHI

  44. Types of memory, dementia, Alzheimer’s disease, and their various pathological cascades as targets for potential pharmacological drugs

    Article • Ageing Research Reviews, April 2024, Elsevier

    Dr RAJENDRA AWASTHI

  45. Nanoliposomes Embedded Nanocochleates for Codelivery of Artemether and Lumefantrine: An In Vitro and In Vivo Study

    Article • Assay and Drug Development Technologies, March 2024, Mary Ann Liebert Inc

    Dr RAJENDRA AWASTHI

  46. STAR particles as potential game-changer in drug delivery and biological processes: Moving beyond conventional nanoparticles

    Article • Journal of Drug Delivery Science and Technology, March 2024, Elsevier

    Dr RAJENDRA AWASTHI

  47. Reactive Astrogliosis and Neuronal Functions of Astrocytes in Neurological Disorders

    Article • Indian Journal of Pharmaceutical Education and Research, February 2024, EManuscript Services

    Dr RAJENDRA AWASTHI

  48. Biogenic metallic nanoparticles as game-changers in targeted cancer therapy: recent innovations and prospects

    Article • Future Journal of Pharmaceutical Sciences, February 2024, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  49. Non-coding RNAs in Regulation of Protein Aggregation and Clearance Pathways: Current Perspectives Towards Alzheimer's Research and Therapy

    Article • Current Gene Therapy, February 2024, Bentham Science Publishers

    Rishabha Malviya, Dr RAJENDRA AWASTHI

  50. Disease X: Beyond Fear, Toward Preparedness

    Article • Infectious Disorders - Drug Targets, January 2024, Bentham Science Publishers

    Dr RAJENDRA AWASTHI

  51. In vitro profiling and molecular dynamics simulation studies of berberine loaded MCM-41 mesoporous silica nanoparticles to prevent neuronal apoptosis

    Article • Nanoscale Advances, January 2024, Royal Society of Chemistry

    Dr RAJENDRA AWASTHI

  52. Neuroprotection induced by sulphoraphane in central nervous system disorders

    Article • January 2024, Elsevier

    Dr RAJENDRA AWASTHI

  53. Letter to the Editor: Concerns Regarding Ethical Issues in Reviewer Recommendations for Citations

    Article • Assay and Drug Development Technologies, December 2023, Mary Ann Liebert Inc

    Dr RAJENDRA AWASTHI

  54. Genetic Causes of Alzheimer’s Disease and the Neuroprotective Role of Melatonin in its Management

    Article • CNS & Neurological Disorders - Drug Targets, November 2023, Bentham Science Publishers

    Dr RAJENDRA AWASTHI

  55. Unlocking new dimensions in rheumatoid arthritis therapy: Harnessing the power of lipid based vesicles beyond traditional therapies

    Article • Journal of Drug Delivery Science and Technology, November 2023, Elsevier

    Dr RAJENDRA AWASTHI

  56. Formulation of Cocos nucifera husk fiber reinforced Acacia chundra gum based hydrogel composite for controlled drug release

    Article • Journal of Drug Delivery Science and Technology, November 2023, Elsevier

    Dr RAJENDRA AWASTHI

  57. Sorafenib tosylate-loaded nanosuspension: preparation, optimization, and in vitro cytotoxicity study against human HepG2 carcinoma cells

    Article • Journal of Chemotherapy, October 2023, Taylor & Francis

    Dr RAJENDRA AWASTHI

  58. Biosensors for Neurodegenerative Diseases

    Article • September 2023, Bentham Science Publishers

    Anand Maurya, Dr RAJENDRA AWASTHI

  59. Emerging Applications of Polymeric Nanoparticles in Tumor Targeting

    Article • Current Nanoscience, September 2023, Bentham Science Publishers

    Dr Dinesh Kumar Chellappan, Parteek Prasher, Dr Monica gulati, Dr RAJENDRA AWASTHI, Dr Gaurav Gupta

  60. Nose-to-brain drug delivery: Challenges and progress towards brain targeting in the treatment of neurological disorders

    Article • Journal of Drug Delivery Science and Technology, September 2023, Elsevier

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  61. Correction to “Lipid-Coated MCM-41 Mesoporous Silica Nanoparticles Loaded with Berberine Improved Inhibition of Acetylcholine Esterase and Amyloid Formation”

    Article • ACS Biomaterials Science & Engineering, July 2023, American Chemical Society (ACS)

    Dr RAJENDRA AWASTHI

  62. Chitosan based sorafenib tosylate loaded magnetic nanoparticles: Formulation and in-vitro characterization

    Article • International Journal of Biological Macromolecules, July 2023, Elsevier

    Dr RAJENDRA AWASTHI, Professor Jaya Parkash Yadav

  63. Breakthroughs and bottlenecks of psoriasis therapy: Emerging trends and advances in lipid based nano-drug delivery platforms for dermal and transdermal drug delivery

    Article • Journal of Drug Delivery Science and Technology, June 2023, Elsevier

    Dr RAJENDRA AWASTHI

  64. Diagnosis and Clinical Aspects of Lung Cancer: A Special Emphasis on Drug Targeting to Cancer Cells through Nanoparticles

    Article • Letters in Drug Design & Discovery, May 2023, Elsevier

    Dr RAJENDRA AWASTHI

  65. Synthesis and Biological Evaluation of Nitro-substituted chalcones as potent Antibacterial and Antifungal agents

    Article • Research Journal of Pharmacy and Technology, April 2023, A and V Publications

    Dr RAJWINDER KAUR, Dr RAJENDRA AWASTHI

  66. Bioinspired microrobots: Opportunities and challenges in targeted cancer therapy

    Article • Journal of Controlled Release, February 2023, Elsevier

    Dr RAJENDRA AWASTHI

  67. Preparation and Optimization of Liposome Containing Thermosensitive In Situ Nasal Hydrogel System for Brain Delivery of Sumatriptan Succinate

    Article • Assay and Drug Development Technologies, January 2023, Mary Ann Liebert Inc

    Dr RAJENDRA AWASTHI

  68. Sorafenib tosylate loaded superparamagnetic nanoparticles: Development, optimization and cytotoxicity analysis on HepG2 human hepatocellular carcinoma cell line

    Article • Journal of Drug Delivery Science and Technology, January 2023, Elsevier

    Dr RAJENDRA AWASTHI

  69. Rational design of linkers in polymer–drug conjugates

    Article • January 2023, Elsevier

    Dr RAJENDRA AWASTHI

  70. Nanovaccine: A Hope to Triumph the Battle Against Novel Coronavirus Disease 2019 (COVID-19)

    Article • Recent Patents on Nanotechnology, December 2022, Bentham Science Publishers

    Dr RAJENDRA AWASTHI

  71. Intranasally Co-administered Berberine and Curcumin Loaded in Transfersomal Vesicles Improved Inhibition of Amyloid Formation and BACE-1

    Article • ACS Omega, November 2022, American Chemical Society (ACS)

    Dr RAJENDRA AWASTHI

  72. Bioelectronic medicines: Therapeutic potential and advancements in next-generation cancer therapy

    Article • Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, November 2022, Elsevier

    Dr RAJENDRA AWASTHI

  73. Hydrogels for localized drug delivery: A special emphasis on dermatologic applications

    Article • Dermatologic Therapy, September 2022, Wiley

    shammy jindal, Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  74. Recent developments, challenges and future prospects in advanced drug delivery systems in the management of tuberculosis

    Article • Journal of Drug Delivery Science and Technology, September 2022, Elsevier

    Dr Keshav Raj Paudel, Dr RAJENDRA AWASTHI, Dr MEHNAZ KAMAL

  75. Formulation and Characterization of Nanostructured Lipid Carriers of Rizatriptan Benzoate-Loaded In Situ Nasal Gel for Brain Targeting

    Article • Assay and Drug Development Technologies, July 2022, Mary Ann Liebert Inc

    Dr RAJENDRA AWASTHI

  76. Evolution of Solid Dispersion Technology: Solubility Enhancement Using Hydroxypropyl Methylcellulose Acetate Succinate: Myth or Reality?

    Article • Assay and Drug Development Technologies, June 2022, Mary Ann Liebert Inc

    Dr RAJENDRA AWASTHI

  77. Optimization Studies on Imatinib Mesylate Loaded Nanoliposomes Using Box-Behnken Design

    Article • Nano Biomedicine and Engineering, April 2022, Elsevier

    Dr RAJENDRA AWASTHI

  78. Precipitation Titration

    Article • February 2022, Bentham Science Publishers

    shammy jindal, Dr. Kamya Goyal, Dr RAJENDRA AWASTHI

  79. Oxygen Flask Combustion Method

    Article • February 2022, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, shammy jindal, Dr. Kamya Goyal

  80. Kjeldahl Method

    Article • February 2022, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, shammy jindal, Dr. Kamya Goyal

  81. Diazotization Method

    Article • February 2022, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, shammy jindal, Dr. Kamya Goyal

  82. Preparation and Evaluation of Gefitinib Containing Nanoliposomal Formulation for Lung Cancer Therapy

    Article • BioNanoScience, January 2022, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  83. Formulation, characterization, and in vitro release studies of modified release multiple unit particulate system (MUPS) of venlafaxine hydrochloride

    Article • Journal of Research in Pharmacy, January 2022, ASOS Yayinevi

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  84. Ethnopharmacological reports on herbs used in the management of tuberculosis

    Article • January 2022, Elsevier

    Dr RAJENDRA AWASTHI

  85. FLOATING IN-SITU RAFT FORMING LIQUID GASTRORETENTIVE DRUG DELIVERY SYSTEM CONTAINING POORLY WATER-SOLUBLE DRUG

    Article • Bulletin of Pharmaceutical Sciences Assiut, December 2021, Egypts Presidential Specialized Council for Education and Scientific Research

    Dr RAJENDRA AWASTHI

  86. Nanosuspensions - An Update on Recent Patents, Methods of Preparation, and Evaluation Parameters

    Article • Recent Patents on Nanotechnology, October 2021, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, Saurabh Satija, Alaa Aljabali, Dr Dinesh Kumar Chellappan

  87. Efficacy of Ulinastatin and Sulforaphane Alone or in Combination in Rat Model of Streptozotocin Diabetes Induced Vascular Dementia

    Article • Clinical Psychopharmacology and Neuroscience, August 2021, Korean College of Neuropsychopharmacology (KAMJE)

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  88. Lipid-Coated MCM-41 Mesoporous Silica Nanoparticles Loaded with Berberine Improved Inhibition of Acetylcholine Esterase and Amyloid Formation

    Article • ACS Biomaterials Science & Engineering, July 2021, American Chemical Society (ACS)

    Dr RAJENDRA AWASTHI

  89. Efavirenz Loaded Mixed Polymeric Micelles: Formulation, Optimization, and In Vitro Characterization

    Article • Assay and Drug Development Technologies, July 2021, Mary Ann Liebert Inc

    Dr RAJENDRA AWASTHI

  90. Stabilization of Etoricoxib Nanosuspension Using Acacia chundra Gum and Copolymers: Preparation, Characterization, and In Vitro Cytotoxic Study

    Article • Assay and Drug Development Technologies, July 2021, Mary Ann Liebert Inc

    Dr RAJENDRA AWASTHI

  91. Behavioral and biochemical investigations to explore the efficacy of quercetin and folacin in experimental diabetes induced vascular endothelium dysfunction and associated dementia in rats

    Article • Journal of Basic and Clinical Physiology and Pharmacology, June 2021, De Gruyter

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  92. Therapeutic Potential of Phytoconstituents in Management of Alzheimer’s Disease

    Article • Evidence-based Complementary and Alternative Medicine, June 2021, Hindawi Publishing Corporation

    Dr RAJENDRA AWASTHI

  93. Albumin-Coated Mesoporous Silica Nanoparticles of Docetaxel: Preparation, Characterization, and Pharmacokinetic Evaluation

    Article • Assay and Drug Development Technologies, May 2021, Mary Ann Liebert Inc

    Dr RAJENDRA AWASTHI

  94. Lipid Nanoparticles as Carriers for Bioactive Delivery

    Article • Frontiers in Chemistry, April 2021, Frontiers

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  95. Chalcones: A review on synthesis and pharmacological activities

    Article • Journal of Applied Biology & Biotechnology, March 2021, Journal of Applied Pharmaceutical Science

    Dr RAJWINDER KAUR, Dr RAJENDRA AWASTHI

  96. Isolation, characterization and evaluation of anti-proliferative properties of andrographolide isolated from Andrographis paniculata on cultured HaCaT cells

    Article • March 2021, Index Copernicus

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  97. Cocrystals of Apixaban with Improved Solubility and Permeability: Formulation, Physicochemical Characterization, Pharmacokinetic Evaluation, and Computational Studies

    Article • Assay and Drug Development Technologies, March 2021, Mary Ann Liebert Inc

    Dr RAJENDRA AWASTHI

  98. Preparation and in vitro evaluation of Tacrolimus loaded liposomal vesicles by two methods: A comparative study

    Article • Journal of Research in Pharmacy, January 2021, ASOS Yayinevi

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  99. Nanocarriers for protein and peptide delivery: Recent advances and progress

    Article • Journal of Research in Pharmacy, January 2021, ASOS Yayinevi

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  100. Immunotherapy for Alzheimer’s Disease: Current Scenario and Future Perspectives

    Article • The Journal of Prevention of Alzheimer s Disease, January 2021, SERDI

    DR VIJAY JAGDISH UPADHYE VIJAY JAGDISH UPADHYE, Dr RAJENDRA AWASTHI

  101. Formulation and evaluation of nano structured lipid carriers for intranasal delivery of Buspirone hydrochloride

    Article • Research Journal of Pharmacy and Technology, January 2021, A and V Publications

    Dr RAJENDRA AWASTHI

  102. Therapeutic implications of inorganic nanoparticles for codelivery of bioactives in cancer therapy

    Article • January 2021, Elsevier

    Dr RAJENDRA AWASTHI

  103. Treatment and Prevention of Osteoporosis during COVID-19 Outbreak: Management and Adherence to Treatment Guidelines

    Article • The Open Public Health Journal, December 2020, Bentham Science Publishers

    Dr RAJENDRA AWASTHI

  104. Solid lipid nanoparticles containing anti-tubercular drugs attenuate the Mycobacterium marinum infection

    Article • Tuberculosis, December 2020, Elsevier

    Dr Keshav Raj Paudel, Dr RAJENDRA AWASTHI

  105. Artificial Intelligence, Blockchain, and Internet of Medical Things: New Technologies in Detecting, Preventing, and Controlling of Emergent Diseases

    Article • November 2020, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  106. Biofabrication: An interesting tool to create in vitro model for COVID-19 drug targets

    Article • Medical Hypotheses, November 2020, Elsevier

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  107. Topical delivery of Tacrolimus using liposome containing gel: An emerging and synergistic approach in management of psoriasis

    Article • Medical Hypotheses, September 2020, Elsevier

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  108. Severity and risk ofCOVID‐19 in cancer patients: An evidence‐based learning

    Article • Dermatologic Therapy, July 2020, Hindawi Publishing Corporation

    Dr RAJENDRA AWASTHI

  109. Molecular mechanisms of action of naringenin in chronic airway diseases

    Article • European Journal of Pharmacology, July 2020, Elsevier

    Dr Keshav Raj Paudel, Conjoint Professor Peter Wark, Dr RAJENDRA AWASTHI

  110. Novel corona virus disease ( COVID ‐19) and ophthalmic manifestations: Clinical evidences

    Article • Dermatologic Therapy, June 2020, Hindawi Publishing Corporation

    Dr RAJENDRA AWASTHI

  111. Novel coronavirus disease 2019 (COVID‐19) and neurodegenerative disorders

    Article • Dermatologic Therapy, May 2020, Hindawi Publishing Corporation

    Dr RAJENDRA AWASTHI

  112. Formulation and In Vitro Evaluation of Casein Nanoparticles as Carrier for Celecoxib

    Article • Advanced Pharmaceutical Bulletin, May 2020, MaadRayan Publishing Company

    Dr RAJENDRA AWASTHI

  113. Development of Mucoadhesive Buccal Drug Delivery System of Propranolol Hydrochloride Using Aster ericoides Mucilage

    Article • Drug Delivery Letters, April 2020, Bentham Science Publishers

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI, Ankaj Kaundal

  114. Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast

    Article • Dermatologic Therapy, April 2020, Hindawi Publishing Corporation

    Dr RAJENDRA AWASTHI

  115. Correction

    Article • Drug Development and Industrial Pharmacy, April 2020, Taylor & Francis

    Dr RAJENDRA AWASTHI

  116. Lipid-PLGA hybrid nanoparticles of paclitaxel: Preparation, characterization, in vitro and in vivo evaluation

    Article • Materials Science and Engineering C, April 2020, Elsevier

    Dr RAJENDRA AWASTHI

  117. Emerging trends in nanomedicine for topical delivery in skin disorders: Current and translational approaches

    Article • Dermatologic Therapy, March 2020, Hindawi Publishing Corporation

    Dr RAJENDRA AWASTHI

  118. Formulation, Optimization, and Evaluation of Ketoconazole Loaded Nanostructured Lipid Carrier Gel for Topical Delivery

    Article • Drug Delivery Letters, February 2020, Bentham Science Publishers

    Dr RAJENDRA AWASTHI

  119. Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles

    Article • Current Alzheimer Research, January 2020, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, Abhimanyu Thakur, Dr Giriraj T Kulkarni, Mr. Anurag Kumar Singh , Anand Maurya

  120. Nanoantibiotic Formulations to Combat Antibiotic Resistance - Old Wine in a New Bottle

    Article • Recent Patents on Drug Delivery & Formulation, January 2020, Bentham Science Publishers

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  121. Formulation, optimization and in vitro evaluation of nanostructured lipid carriers for topical delivery of apremilast

    Article • January 2020, Beilstein Institut

    Dr RAJENDRA AWASTHI

  122. Therapeutic Benefits of Saffron in Brain Diseases

    Article • January 2020, Elsevier

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  123. Inorganic clay nanocomposite system for improved cholinesterase inhibition and brain pharmacokinetics of donepezil

    Article • Drug Development and Industrial Pharmacy, December 2019, Taylor & Francis

    Mr. Anurag Kumar Singh , Dr RAJENDRA AWASTHI

  124. Formulation and evaluation of solid self-microemulsifying drug delivery system for azilsartan medoxomil

    Article • International Journal of Polymeric Materials, November 2019, Taylor & Francis

    Dr RAJENDRA AWASTHI

  125. Grewia asiatica mucilage: A smart gelling polymeric material for pharmaceutical applications - in vitro studies

    Article • Current Materials Science, November 2019, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, Dr Giriraj T Kulkarni

  126. Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer’s disease

    Article • Central Nervous System Agents in Medicinal Chemistry, October 2019, Bentham Science Publishers

    Mr. Anurag Kumar Singh , Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  127. Plant Derived Polysaccharides as Pharmaceutical Excipients: An Overview

    Article • September 2019, Springer Science + Business Media

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  128. Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases

    Article • Chemico-Biological Interactions, August 2019, Elsevier

    Dr RAJENDRA AWASTHI

  129. The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress

    Article • Drug Development Research, July 2019, Wiley

    Dr RAJENDRA AWASTHI

  130. Formulation and solid state characterization of carboxylic acid-based co-crystals of tinidazole: An approach to enhance solubility

    Article • Polymers in Medicine, April 2019, Wroclaw Medical University

    Dr RAJENDRA AWASTHI

  131. Strategic use of nanotechnology in drug targeting and its consequences on human health: A focused review

    Article • Interventional Medicine and Applied Science, March 2019, Akademiai Kiado

    Dr RAJENDRA AWASTHI, Mr. Anurag Kumar Singh , Dr Giriraj T Kulkarni

  132. Therapeutic strategies for targeting non-coding RNAs with special emphasis on novel delivery systems

    Article • Non-coding RNA Investigation, March 2019, AME Publishing Company

    Dr RAJENDRA AWASTHI

  133. Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: An emerging need for novel drug delivery systems

    Article • Chemico-Biological Interactions, February 2019, Elsevier

    Dr RAJENDRA AWASTHI

  134. Preparation, characterization and in vitro evaluation of tablets containing microwave-assisted solid dispersions of apremilast

    Article • Polymers in Medicine, January 2019, Wroclaw Medical University

    Dr RAJENDRA AWASTHI

  135. Antibacterial and In Vitro Growth Inhibition Study of Struvite Urinary Stones Using Oxalis corniculata Linn. Leaf Extract and its Biofabricated Silver Nanoparticles

    Article • Recent Patents on Drug Delivery & Formulation, January 2019, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, Himaja Malipeddi

  136. Aqueous Extract of Wood Ear Mushroom, Auricularia polytricha (Agaricomycetes), Demonstrated Antiepileptic Activity against Seizure Induced by Maximal Electroshock and Isoniazid in Experimental Animals

    Article • International Journal of Medicinal Mushrooms, January 2019, Begell House

    Dr RAJENDRA AWASTHI

  137. Skin Targeting of Oxiconazole Nitrate Loaded Nanostructured Lipid- Carrier Gel for Fungal Infections

    Article • Pharmaceutical Nanotechnology, December 2018, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, Kishore Gujar

  138. Novel drug delivery approaches in treating pulmonary fibrosis

    Article • Panminerva Medica, December 2018, Edizioni Minerva Medica

    Dr RAJENDRA AWASTHI

  139. Nanoparticles in Cancer Treatment: Opportunities and Obstacles

    Article • Current Drug Targets, September 2018, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, Phil Hansbro

  140. Evaluation of an Amplified ATP Bioluminescence Method for Rapid Sterility Testing of Large Volume Parenteral

    Article • Journal of Pharmaceutical Innovation, September 2018, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  141. Why is there an emerging need to look for a suitable drug delivery platform in targeting and regulating microbiota?

    Article • Panminerva Medica, September 2018, Edizioni Minerva Medica

    Dr RAJENDRA AWASTHI

  142. Formulation and evaluation of controlled-release matrix systems of ciprofloxacin

    Article • Polymers in Medicine, June 2018, Wroclaw Medical University

    Dr RAJENDRA AWASTHI

  143. Improving dissolution profile of poorly water-soluble drug using non-ordered mesoporous silica

    Article • Marmara Pharmaceutical Journal, April 2018, Marmara Pharmaceutical Journal

    Dr RAJENDRA AWASTHI

  144. Matrix-assisted laser desorption ionization–time of flight mass spectrometry for identification of bacteria isolated from pharmaceutical clean rooms

    Article • Interventional Medicine and Applied Science, March 2018, Akademiai Kiado

    Dr RAJENDRA AWASTHI

  145. Application of Chitosan and its Derivatives in Nanocarrier Based Pulmonary Drug Delivery Systems

    Article • Pharmaceutical Nanotechnology, January 2018, Bentham Science Publishers

    Dr RAJENDRA AWASTHI

  146. PHYTOSOME: MOST SIGNIFICANT TOOL FOR HERBAL DRUG DELIVERY TO ENHANCE THE THERAPEUTIC BENEFITS OF PHYTOCONSTITUENTS

    Article • Journal of Drug Delivery and Therapeutics, January 2018, Society of Pharmaceutical Tecnocrats

    Dr RAJENDRA AWASTHI

  147. Evaluating the Potential, Applicability, and Effectiveness of Ozone Sterilization Process for Medical Devices

    Article • Journal of Pharmaceutical Innovation, January 2018, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  148. An Overview of Circular RNAs

    Article • January 2018, Springer Science + Business Media

    Mr. Anurag Kumar Singh , Dr RAJENDRA AWASTHI

  149. Formulation, Characterization and In-vitro Evaluation of Fast Dissolv ing Tablets Containing Gliclazide Hydrotropic Solid Dispersions

    Article • Recent Patents on Drug Delivery & Formulation, December 2017, Bentham Science Publishers

    Dr RAJENDRA AWASTHI

  150. Performance Survey and Comparison Between Rapid Sterility Testing Method and Pharmacopoeia Sterility Test

    Article • Journal of Pharmaceutical Innovation, December 2017, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  151. Improving the solubility of nevirapine using a hydrotropy and mixed hydrotropy based solid dispersion approach

    Article • Polymers in Medicine, December 2017, Wroclaw Medical University

    Dr RAJENDRA AWASTHI

  152. Formation of struvite urinary stones and approaches towards the inhibition—A review

    Article • Biomedicine & Pharmacotherapy, December 2017, Elsevier

    Dr RAJENDRA AWASTHI

  153. Therapeutic prospects of microRNAs in cancer treatment through nanotechnology

    Article • Drug Delivery and Translational Research, November 2017, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  154. Potential therapeutic activity of Phlogacanthus thyrsiformis Hardow (Mabb) flower extract and its biofabricated silver nanoparticles against chemically induced urolithiasis in male Wistar rats

    Article • International Journal of Biological Macromolecules, October 2017, Elsevier

    Dr RAJENDRA AWASTHI

  155. Dual crosslinked pectin–alginate network as sustained release hydrophilic matrix for repaglinide

    Article • International Journal of Biological Macromolecules, April 2017, Elsevier

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  156. Hydrogel based drug delivery systems: A review with special emphasis on challenges associated with decontamination of hydrogels and biomaterials

    Article • Current Drug Delivery, December 2016, Bentham Science Publishers

    Dr RAJENDRA AWASTHI

  157. Opportunities and Challenges in Nano-structure Mediated Drug Delivery: Where Do We Stand?

    Article • Current Nanomedicine, October 2016, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, Dr Giriraj T Kulkarni

  158. Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system

    Article • Drug Delivery and Translational Research, September 2016, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  159. Formulation and evaluation of controlled release ethylcellulose and polyethylene glycol microspheres containing metoprolol tartrate

    Article • Interventional Medicine and Applied Science, June 2016, Akademiai Kiado

    Dr RAJENDRA AWASTHI

  160. Norfloxacin and metronidazole topical formulations for effective treatment of bacterial infections and burn wounds

    Article • Interventional Medicine and Applied Science, June 2016, Akademiai Kiado

    Dr RAJENDRA AWASTHI

  161. Development and characterization of solid dispersion-microsphere controlled release system for poorly water-soluble drug

    Article • Drug Delivery and Translational Research, June 2016, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  162. Investigation on binding properties of Grewia asiatica mucilage in tablet formulations

    Article • Marmara Pharmaceutical Journal, May 2016, Marmara Pharmaceutical Journal

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  163. Piperine containing floating microspheres: an approach for drug targeting to the upper gastrointestinal tract

    Article • Drug Delivery and Translational Research, February 2016, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  164. Gastroretentive floating tablets: An investigation of excipients effect on tablet properties

    Article • Marmara Pharmaceutical Journal, February 2016, Marmara Pharmaceutical Journal

    Dr RAJENDRA AWASTHI

  165. Development of Ocular Delivery System for Glaucoma Therapy Using Natural Hydrogel as Film Forming Agent and Release Modifier

    Article • Polymers in Medicine, January 2016, Wroclaw Medical University

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  166. Development of Bilayer Tablets with Modified Release of Selected Incompatible Drugs

    Article • Polymers in Medicine, January 2016, Wroclaw Medical University

    Dr RAJENDRA AWASTHI

  167. Frontier lipid-based carrier systems for drug targeting: A laconic review on niosomes

    Article • Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, May 2015, Bentham Science Publishers

    Dr RAJENDRA AWASTHI

  168. Frontier Lipid-Based Carrier Systems for Drug Targeting: A Laconic Review on Niosomes

    Article • Pharmaceutical Nanotechnology, February 2015, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, Dr Giriraj T Kulkarni

  169. Development of Metronidazole-Loaded Colon-Targeted Microparticulate Drug Delivery System

    Article • Polymers in Medicine, January 2015, Wroclaw Medical University

    Dr RAJENDRA AWASTHI

  170. Development of Dehydration-Rehydration Liposomal System Using Film Hydration Technique Followed by Sonication

    Article • Current Drug Delivery, December 2014, Bentham Science Publishers

    Dr RAJENDRA AWASTHI

  171. Decades of research in drug targeting to the upper gastrointestinal tract using gastroretention technologies: where do we stand?

    Article • Drug Delivery, July 2014, Taylor & Francis

    Dr RAJENDRA AWASTHI, Dr Giriraj T Kulkarni

  172. Development and characterization of amoxicillin loaded floating microballoons for the treatment of Helicobacter pylori induced gastric ulcer

    Article • Asian Journal of Pharmaceutical Sciences, June 2013, Elsevier

    Dr RAJENDRA AWASTHI, Dr Giriraj T Kulkarni

  173. Development of novel gastroretentive drug delivery system of gliclazide: hollow beads

    Article • Drug Development and Industrial Pharmacy, February 2013, Taylor & Francis

    Dr RAJENDRA AWASTHI, Dr Giriraj T Kulkarni

  174. Development of Novel Gastroretentive Floating Particulate Drug Delivery System of Gliclazide

    Article • Current Drug Delivery, August 2012, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, Dr Giriraj T Kulkarni

  175. Optimization Studies on Gastroretentive Floating System Using Response Surface Methodology

    Article • AAPS PharmSciTech, December 2011, American Association of Pharmaceutical Scientists (AAPS)

    Dr RAJENDRA AWASTHI, Dr Giriraj T Kulkarni

  176. Gastroretentive dosage forms: A review with special emphasis on floating drug delivery systems

    Article • Drug Delivery, October 2010, Taylor & Francis

    Dr RAJENDRA AWASTHI, Dr Giriraj T Kulkarni